SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-127351
Filing Date
2017-04-18
Accepted
2017-04-18 16:01:11
Documents
9
Effectiveness Date
2017-04-18

Document Format Files

Seq Description Document Type Size
1 8-K d384556d8k.htm DEFA14A 64206
2 EX-2.1 d384556dex21.htm EX-2.1 458327
3 EX-10.1 d384556dex101.htm EX-10.1 85257
4 EX-99.1 d384556dex991.htm EX-99.1 543708
5 EX-99.2 d384556dex992.htm EX-99.2 38116
6 EX-99.3 d384556dex993.htm EX-99.3 7237
7 GRAPHIC g384556g0414131903434.jpg GRAPHIC 2506
8 GRAPHIC g384556g0414131903512.jpg GRAPHIC 2778
9 GRAPHIC g384556g0414133732412.jpg GRAPHIC 1535
  Complete submission text file 0001193125-17-127351.txt   1207902
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36828 | Film No.: 17767033
SIC: 2834 Pharmaceutical Preparations